These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 33223085)

  • 1. Advances in the Treatment of Multiple Sclerosis.
    Goldschmidt C; McGinley MP
    Neurol Clin; 2021 Feb; 39(1):21-33. PubMed ID: 33223085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward the development of rational therapies in multiple sclerosis: what is on the horizon?
    Hemmer B; Hartung HP
    Ann Neurol; 2007 Oct; 62(4):314-26. PubMed ID: 17969020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches to neuroprotective strategies in multiple sclerosis.
    Tselis A; Khan OA; Lisak RP
    Expert Opin Pharmacother; 2010 Dec; 11(17):2869-78. PubMed ID: 20687779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage between immunomodulation, neuroprotection and neurogenesis.
    Aharoni R; Arnon R
    Drug News Perspect; 2009; 22(6):301-12. PubMed ID: 19771319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of action and clinical studies with fumarates in multiple sclerosis.
    Salmen A; Gold R
    Exp Neurol; 2014 Dec; 262 Pt A():52-6. PubMed ID: 24568735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapeutic approaches for multiple sclerosis.
    De Jager PL; Hafler DA
    Annu Rev Med; 2007; 58():417-32. PubMed ID: 17217332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MS pipeline flowing, but niche remains for neuroprotection.
    Waters H
    Nat Med; 2011 Nov; 17(11):1327. PubMed ID: 22064394
    [No Abstract]   [Full Text] [Related]  

  • 8. Emerging disease modifying therapies for multiple sclerosis.
    Waubant E
    Expert Opin Emerg Drugs; 2003 May; 8(1):145-61. PubMed ID: 14610918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection in multiple sclerosis: therapeutic strategies and clinical trial design.
    Kapoor R
    Curr Opin Neurol; 2006 Jun; 19(3):255-9. PubMed ID: 16702831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multiple sclerosis at the time of world-wide use of disease modifying treatment].
    Gusev EI; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7 Suppl 2):4-9. PubMed ID: 19894306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis.
    Aktas O; Kieseier B; Hartung HP
    Trends Neurosci; 2010 Mar; 33(3):140-52. PubMed ID: 20045200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New therapeutic strategies for remyelination in multiple sclerosis].
    Kremer D; Hartung HP; Stangel M; Küry P
    Nervenarzt; 2015 Aug; 86(8):934-46. PubMed ID: 26122637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapies for multiple sclerosis: translational achievements and outstanding needs.
    Haghikia A; Hohlfeld R; Gold R; Fugger L
    Trends Mol Med; 2013 May; 19(5):309-19. PubMed ID: 23582699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroprotection in the treatment of multiple sclerosis].
    Zipp F; Gold R
    Nervenarzt; 2011 Aug; 82(8):973-7. PubMed ID: 21761185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic strategies in multiple sclerosis: a focus on neuroprotection and repair and relevance to schizophrenia.
    Inglese M; Petracca M
    Schizophr Res; 2015 Jan; 161(1):94-101. PubMed ID: 24893901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis - established and novel therapeutic approaches.
    Ehling R; Berger T; Reindl M
    Cent Nerv Syst Agents Med Chem; 2010 Mar; 10(1):3-15. PubMed ID: 20236038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-modifying treatments for progressive multiple sclerosis.
    Comi G
    Mult Scler; 2013 Oct; 19(11):1428-36. PubMed ID: 24062415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
    Wingerchuk DM; Carter JL
    Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of statins in the treatment of multiple sclerosis.
    Ciurleo R; Bramanti P; Marino S
    Pharmacol Res; 2014 Sep; 87():133-43. PubMed ID: 24657241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Update on pathophysiologic and immunotherapeutic approaches for the treatment of multiple sclerosis].
    Kleinschnitz C; Meuth SG; Kieseier BC; Wiendl H
    Nervenarzt; 2007 Aug; 78(8):883-911. PubMed ID: 17551708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.